Inhibition of anaphylaxis like reaction and mast cell activation by Sitagliptin

International Immunopharmacology

Volumn 11, Issue 8, 2011, Pages 1052-1056

  Nader, Manar A ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Histamine; Mast cell; Pro inflammatory cytokine; Sitagliptin; TNF

Indexed keywords

HISTAMINE; IMMUNOGLOBULIN E; SITAGLIPTIN; TUMOR NECROSIS FACTOR ALPHA;

ALLERGY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AQUEOUS SOLUTION; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; HISTAMINE RELEASE; MALE; MAST CELL; MOUSE; NONHUMAN; PERITONEUM MAST CELL; PRIORITY JOURNAL; SKIN ANAPHYLAXIS;

EID: 84860418989     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2011.02.026     Document Type: Article

References (34)

1. Kumar A, Prasad R, Jogge NM, Bhojraj S, Emerson SF, Prabakar S. Herbex-kid inhibits immediate hypersensitivity reactions in mice and rats. eCAM 2008;5: 289-94.
2. Lagunoff D, Martin TW, Read G. Agents that release histamine from mast cells. Annu Rev Pharmacol Toxicol 1983;23:331-51. (Pubitemid 13079379)
3. Ennis M, Pearce FL, Weston PM. Some studies on the release of histamine from mast cells stimulated with polylysine. Br J Pharmacol 1980;70:329-34. (Pubitemid 10004551)
4. Kemp SF, Lockey RF. Anaphylaxis: a review of causes and mechanisms. J Allergy Clin Immunol 2002;110:341-8.
5. Metzger H, Alcaraz G, Hohman R, Kinet JP, Pribluda V, Quarto R. The receptor with high affinity for immunoglobulin E. Annu Rev Immunol 1986;4:419-70.
6. Galli SJ, Kalesnikoff J, Grimbaldeston MA, Piliponsky AM, Williams CM, Tsai M, et al. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu Rev Immunol 2005;23:749-86. (Pubitemid 40563184)
7. Petersen LJ, Mosbech H, Skov PS. Allergen-induced histamine release in intact human skin in vivo assessed by skin microdialysis technique: characterization of factors influencing histamine releasability. J Allergy Clin Immunol 1996;97:672-9. (Pubitemid 26062766)
8. Beaven MA, Rogers J, Moore JP, Hesketh TR, Smith GA, Metcalfe JC. The mechanism of the calcium signal and correlation with histamine release in 2H3 cells. J Biol Chem 1984;259:7129-36. (Pubitemid 14077793)
9. Metcalfe DD, Kaliner M, Donlon MA. Themast cell. CRC CritRevImmunol 1981;3:23-74.
10. Bradding P, Feather IH, Wilson S, Bardin PG, Heusser CH, Holgate ST, et al. Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. J Immunol 1993;151:3853-65.
11. Burd PR, Rogers HW, Gordon JR, Martin CA, Jayaraman S, Wilson SD. Interleukin-3- dependent and independent mast cells stimulated with IgE and antigen express multiple cytokines. J Exp Med 1989;170:245-57. (Pubitemid 19179708)
12. Plaut M, Pierce JH, Watson CJ, Hanley-Hyde J, Nordan RP, Paul WE. Mast cell lines produce lymphokines in response to cross-linkage of FcR1 or to calcium ionophore. Nat Lond 1989;339:64-7. (Pubitemid 19115894)
13. Mest HJ, Mentlein R. Dipeptidyl peptidase inhibitors as new drugs for the treatment of type 2 diabetes. Diabetologia 2005;48:616-20. (Pubitemid 40591214)
14. Raz I, Hanefeld M, Xu L, Caria C, Williams-Herman D, Khatami H. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus. Diabetologia 2006;49:2564-71.
15. Thorens B. Expression cloning of the pancreatic b cell receptor for the glucoincretin hormone glucagon like peptide 1. PNAS 1992;89:8641-5.
16. Schade J, Stephan M, Schmiedl A. Regulation of expression and function of dipeptidyl peptidase 4 (DP4), DP8/9, and DP10 in allergic responses of the lung in rats. J Histochem Cytochem 2008;56:147-55. (Pubitemid 351170967)
17. Yazbeck R, Howarth GS, Abbott CA. Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease? Trends Pharmacol Sci 2009;30:600-7.
18. Coleman JW, Layton GT, Stanworth DR. The kinetics of in vivo sensitization of rat peritoneal and lung mast cells: temporal dissociation from circulating levels of IgE. Eur J Immunol 1993;13:994-8.
19. Portela CP, Tibério FLC, Leick-Maldonado EA, Martins MA, Palermo-Neto J. Effects of diazepam and stress on lung inflammatory response in OVA-sensitized rats. Am J Physiol 2002;282:L1289-95. (Pubitemid 34654585)
20. Park KH, Park J, Koh D, Lim Y. Effect of saikosaponin-A, a triterpenoid glycoside, isolated from Bupleurum falcatum on experimental allergic asthma. Phytother Res 2002;16:359-63. (Pubitemid 34700275)
21. Haddad EB, Underwood SL, Dabrowski D, Birrell MA, McCluskie K, Battram CH, et al. Critical role for T Cells in sephadex-induced airway inflammation: pharmacological and immunological characterization and molecular biomarker identification. J Immunol 2002;168:3004-16. (Pubitemid 34211682)
22. Katayama S, Shionoya H, Ohtake S. A new method for extraction of extravasated dye in the skin and the influence of fasting stress on passive cutaneous allergy in guinea pigs and rats. Microbiol Immunol 1978;22:89-101. (Pubitemid 8346231)
23. Kubo M, Matsuda H, Tokuoka K, Ma S, Shiomoto H. Anti-inflammatory activities of methanolic extract and alkaloidal components from Corydalis tuber. Biol Pharm Bull 1994;17:262-5. (Pubitemid 24112347)
24. Yurt RW, Leid RW, Austen KF. Native heparin from rat peritoneal mast cells. J Biol Chem 1977;252:518-21. (Pubitemid 8065326)
25. Shuto H, Sueyasu M, Otsuki S, Hara T, Tsuruta Y, Kataoka Y, et al. Potentiation of vancomycin-induced histamine release by muscle relaxants and morphine in rats. Antimicrob Agents Chemother 1999;43:2881-4.
26. Shore PA, Burkhalter A, Cohn VH. A method for fluorometric assay of histamine in tissues. J Pharmacol Exp Ther 1959;127:182-6.
27. Boonacker E, Van Noorden CJ. The multifunctional or moonlighting protein CD26/ DPPIV. Eur J Cell Biol 2003;82:53-73. (Pubitemid 36285042)
28. Amir S, English AM. An inhibitor of nitric oxide production, NG-nitro-L-argininemethyl ester, improves survival in anaphylactic shook. Eur J Pharmacol 1991;203: 125-7.
29. Kim HM, Lee EH, Lee JH, Jung JA, Kim JJ. Salviae radix root extract inhibits immunoglobulin E-mediated allergic reaction. Gen Pharmacol 1999;32:603-8.
30. Mousli M, Bronner C, Bockaert J, Rouot B, Landry Y. Interaction of substance P, compound 48/80 and mastoparan with the alpha-subunit C-terminus of G protein. Immumol Lett 1990;25:355-7.
31. Saito H, Nomura Y. Screening methods for drug evaluation 3. In: Suzuki L, Tanaka H, Yajima H, Fukuda H, Sezaki H, Koga K, et al, editors. Pharmaceutical research and development, Hirokawa, Tokyo; 1989. p. 22.
32. Neel NF, Creasy BM, Rankin JN, Pierce EM, McCoy ME, Daner RH, et al. Absence of interleukin-3 does not affect the severity of local and systemic anaphylaxis but does enhance eosinophil infiltration in a mouse model of allergic peritonitis. Immunol Lett 2004;95:37-44. (Pubitemid 39119898)
33. Hide I, Toriu N, Nuibe T, Inoue A, Hide M, Yamamoto S, et al. Suppression of TNF-alpha secretion by azelastine in a rat mast (RBL-2H3) cell line: evidence for differential regulation of TNF-alpha release, transcription, and degranulation. J Immunol 1997;159:2932-40. (Pubitemid 127681316)
34. Jeong HJ, Koo HN, Na HJ, Kim MS, Hong SH, Eom JW, et al. Inhibition of the TNF-α and IL-6 production by aucubin through blockade of NF-κB activation in RBL-2H3 mast cell. Cytokine 2002;18:252-9.